Buttgereit F - Search Results

1

Optimised glucocorticoid therapy: the sharpening of an old spear.

Buttgereit F, Burmester GR, Lipworth BJ. Buttgereit F, et al. Lancet. 2005 Feb 26-Mar 4;365(9461):801-3. doi: 10.1016/S0140-6736(05)17989-6. Lancet. 2005. PMID: 15733723 Review.

2

[Therapy of rheumatic diseases with methylprednisolone--mechanism of action and clinical applications].

Buttgereit F. Buttgereit F. Z Arztl Fortbild (Jena). 1994 Nov;88(11):897-902. Z Arztl Fortbild (Jena). 1994. PMID: 7839711 Review. German. No abstract available.

3

[Mechanisms of action of high-dosage glucocorticoid therapy].

Buttgereit F, Dimmeler S, Neugebauer E, Burmester GR. Buttgereit F, et al. Dtsch Med Wochenschr. 1996 Feb 23;121(8):248-52. doi: 10.1055/s-2008-1043001. Dtsch Med Wochenschr. 1996. PMID: 8815025 Review. German. No abstract available.

4

[The therapeutic potential of lazaroids (21-aminosteroids). A recent survey].

Buttgereit F, Hiepe F, Burmester GR. Buttgereit F, et al. Dtsch Med Wochenschr. 1997 Oct 31;122(44):1363-7. doi: 10.1055/s-2008-1047772. Dtsch Med Wochenschr. 1997. PMID: 9410710 Review. German. No abstract available.

5

A new hypothesis of modular glucocorticoid actions: steroid treatment of rheumatic diseases revisited.

Buttgereit F, Wehling M, Burmester GR. Buttgereit F, et al. Arthritis Rheum. 1998 May;41(5):761-7. doi: 10.1002/1529-0131(199805)41:5<761::AID-ART2>3.0.CO;2-M. Arthritis Rheum. 1998. PMID: 9588727 Review. No abstract available.

6

Clinical image: Isolated arteritis of the superior mesenteric artery with positive perinuclear antineutrophil cytoplasmic antibody.

Buttgereit F, Wermke W, Hiepe F, Burmester GR. Buttgereit F, et al. Arthritis Rheum. 1998 Sep;41(9):1701. doi: 10.1002/1529-0131(199809)41:9<1701::AID-ART23>3.0.CO;2-L. Arthritis Rheum. 1998. PMID: 9751105 No abstract available.

7

Equivalent doses and relative drug potencies for non-genomic glucocorticoid effects: a novel glucocorticoid hierarchy.

Buttgereit F, Brand MD, Burmester GR. Buttgereit F, et al. Biochem Pharmacol. 1999 Jul 15;58(2):363-8. doi: 10.1016/s0006-2952(99)00090-8. Biochem Pharmacol. 1999. PMID: 10423179

8

Therapeutically targeting lymphocyte energy metabolism by high-dose glucocorticoids.

Buttgereit F, Burmester GR, Brand MD. Buttgereit F, et al. Biochem Pharmacol. 2000 Mar 15;59(6):597-603. doi: 10.1016/s0006-2952(99)00273-7. Biochem Pharmacol. 2000. PMID: 10677575

9

Bioenergetics of immune functions: fundamental and therapeutic aspects.

Buttgereit F, Burmester GR, Brand MD. Buttgereit F, et al. Immunol Today. 2000 Apr;21(4):192-9. doi: 10.1016/s0167-5699(00)01593-0. Immunol Today. 2000. PMID: 10740243 Review. No abstract available.

10

Glucocorticoid dose dependent downregulation of glucocorticoid receptors in patients with rheumatic diseases.

Sanden S, Tripmacher R, Weltrich R, Rohde W, Hiepe F, Burmester GR, Buttgereit F. Sanden S, et al. Among authors: buttgereit f. J Rheumatol. 2000 May;27(5):1265-70. J Rheumatol. 2000. PMID: 10813299

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results